Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

NCT01738815 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT01738815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01738815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
Lead sponsor
State University of New York - Upstate Medical University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2011
Completion date
April 30, 2014
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria